CARLBIOTECH LTD AS has a total of 81 patent applications. Its first patent ever was published in 1988. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are ROCHE GLYCART AG, SYMPHOGEN AS and ARMAGEN TECHNOLOGIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 14 | |
#2 | WIPO (World Intellectual Property Organization) | 10 | |
#3 | Canada | 7 | |
#4 | Denmark | 7 | |
#5 | Australia | 6 | |
#6 | Ireland | 5 | |
#7 | Israel | 5 | |
#8 | United States | 4 | |
#9 | China | 3 | |
#10 | Hong Kong | 3 | |
#11 | Norway | 3 | |
#12 | New Zealand | 3 | |
#13 | Sweden | 2 | |
#14 | South Africa | 2 | |
#15 | Czechoslovakia | 1 | |
#16 | Finland | 1 | |
#17 | Hungary | 1 | |
#18 | Japan | 1 | |
#19 | Latvia | 1 | |
#20 | Russian Federation | 1 | |
#21 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Organic fine chemistry | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Fermentation | |
#8 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Widmer Fred | 33 |
#2 | Aasmul-Olsen Stig | 30 |
#3 | Rasmussen Palle H | 17 |
#4 | Rasmussen Jon H | 17 |
#5 | Gauri Kailash Kumar | 15 |
#6 | Fomsgaard Jens | 13 |
#7 | Hansen Stefan | 8 |
#8 | Wachs Wolfgang O | 7 |
#9 | Macfadden D K | 7 |
#10 | Christensen Kurt Asbaek | 6 |
Publication | Filing date | Title |
---|---|---|
SG175744A1 | Method for the manufacture of degarelix | |
NZ534245A | Intermediates for LHRH antagonist synthesis, process for their production, and process for LHRH antagonist production | |
NZ534151A | A process of purification of an otherwise pure nona- or decapeptide from residual organic solvent | |
DK64592D0 | Peptides for therapeutic treatment | |
DK67691D0 | Enzymatic procedure for c-terminal modification of peptides and intermediates for use by the procedure | |
DK53291D0 | Small peptides and peptid related substances and pharmaceutical preparations containing such compounds | |
DK53191D0 | Organosular compound and pharmaceutical preparation containing such a connection | |
DK37391D0 | Enzymatic procedure for c-terminal amidation of peptides and intermediates for use by the procedure | |
DK31991D0 | Peptid and pharmaceutical preparation containing such peptid | |
AU6898991A | Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma | |
AU6075890A | A process for chiral enrichment of asymmetric primary amines | |
WO9119002A1 | A process for chiral enrichment of asymmetric primary amines |